Dominique Costagliola
0000-0003-0765-0869
429 papers found
Refreshing results…
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals
Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination
Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era:
Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort
Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4
Sleep quality, chronotype and metabolic syndrome components in bipolar disorders during the remission period: Results from the FACE-BD cohort
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study
The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe
Lack of effects of statins on high-density lipoprotein subfractions in HIV-1-infected patients receiving protease inhibitors
Outcomes for bipolar patients assessed in the French expert center network: A 2-year follow-up observational study (FondaMental Advanced Centers of Expertise for Bipolar Disorder FACE-BD )
Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression
Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudy
CD4 cell count response to first-line combination ART in HIV-2+patients compared with HIV-1+patients: a multinational, multicohort European study
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France:
HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens: Table 1.
Cancers in elite controllers
Beyond viral suppression of HIV – the new quality of life frontier
Missing publications? Search for publications with a matching author name.